Biotech Gainers At Midday
October 5th, 2009Tags: AVII, bio-pharmaceuticals, Biotech, DEPO, DOD, FDA
Calgary, Alberta - PicksThatMove.com opines promising trading opportunities with likely potential for gain. The companies we follow have favourable revenue models for business development at upward cycles. Please visit us at PicksThatMove.com to view more of our profiled stocks.
Biotech Gainers At Midday
The hot stock information of the day includes: DEPO, AVII
DepoMed, Inc. (NASDAQ:DEPO) jumped 25.62% up to $5.54 on heavy volume with news the company’s drug candidate DM-1796 demonstrated excellent results in Phase lll trials and significantly reduced pain associated with postherpetic neuralgia. Post herpetic neuralgia is severe pain caused by nerve damaged from complications resulting from shingles. DepoMed expects to submit the marketing application for DM-1796 to the FDA by the end of the first quarter of 2010. Based in Menlo Park, California, DepoMed, Inc is a specialty pharmaceutical company, which develops and commercializes therapeutic products in the US, based on proprietary oral drug delivery technologies. The company sells Glumetza in the US, Canada and Korea for the treatment of type ll diabetes and Proquin XR in the US for the treatment of urinary tract infection. DepoMedo currently has four drug candidates in trials including DM-5689 in Phase lll trails for the relief of menopausal hot flashes; DM-1796 in Phase lll trials for the treatment of postherpetic neuralgia and diabetic postherpetic neuralgia; Phase ll trials for DM-3458 for the relief of Gastroesophageal reflux; and DM-1992 which has successfully concluded pre-clinical trials for the treatment of Parkinson’s Disease.
AVI BioPharma, Inc. (NASDAQ:AVII) gained 28.21% up to $2.00 on news AVI BioPharma Inc received another $11.5 million from the US Department of Defense to develop its drug candidate for the treatment of Junin virus infection. Junin virus causes Argentinian hemorrhagic fever which can be fatal, and is transmitted by rats. Based in Portland, Oregon, AVI BioPharma, Inc is a biopharmaceutical company which uses gene research to discover and develop new therapies and vaccines.
To be kept up to date on all of our hot stock information join us at Picks That Move.
About PicksThatMove.com:
PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies. PicksThatMove.com is not a registered investment advisor or broker-dealer. PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value. We recommend Due Diligence before investing in any stock.
Related posts:
- Pharmaceuticals And BioTech Midday Gainers NYER jumped 181.71% up to $1.95 at midday on news...
- Biotech Gainers Beating The Down Trend: ENCO, ENMD, ONCY ENMD up 15.35% on no news since the company advised...
- Corcept Therapeutics, BioTime, Inc Lead Biotech Gainers BioTime, Inc. jumped 19.37% to close at $6.10 on news...
- Nutraceutical And Bioharmaceutical Gainers At Midday Forbes Medi-Tech Inc. (USA) (NASDAQ:FMTI) soared 102.70% up to $0.75...
- ENCO, TPTX, TGEN: Biopharmaceutical And Biotech Gainers Leading The Sector Encorium Group Inc. surged 276.76% up to $0.791 on news...
Related posts brought to you by Yet Another Related Posts Plugin.


